Nunes Anne
Insider CIK 1982862 · ANIK SVP, Chief Operations Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2025-03-17 | 2025-03-18 | 3,637 | — | $0 | 7,275 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2025-03-17 | 2025-03-18 | 3,637 | — | $0 | 21,722 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2025-03-17 | 2025-03-18 | 1,068 | $15.91 | $17.0K | 20,654 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2025-03-14 | 2025-03-18 | 4,650 | — | $0 | 4,650 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2025-03-14 | 2025-03-18 | 20,761 | — | $0 | 20,761 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2025-03-11 | 2025-03-13 | 2,561 | — | $0 | 0 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2025-03-11 | 2025-03-13 | 752 | $16.79 | $12.6K | 18,085 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2025-03-11 | 2025-03-13 | 2,561 | — | $0 | 18,837 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2025-03-10 | 2025-03-11 | 3,296 | — | $0 | 3,295 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2025-03-10 | 2025-03-11 | 959 | $16.62 | $15.9K | 16,276 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2025-03-10 | 2025-03-11 | 3,296 | — | $0 | 17,235 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2024-10-01 | 2024-10-04 | 2,491 | — | $0 | 0 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2024-10-01 | 2024-10-04 | 732 | $24.27 | $17.8K | 13,479 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2024-10-01 | 2024-10-04 | 2,491 | — | $0 | 14,211 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2024-03-15 | 2024-03-19 | 10,912 | — | $0 | 10,912 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2024-03-15 | 2024-03-19 | 26,442 | — | $0 | 26,442 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2024-03-11 | 2024-03-12 | 3,295 | — | $0 | 6,591 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2024-03-11 | 2024-03-12 | 2,561 | — | $0 | 2,561 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2024-03-11 | 2024-03-12 | 752 | $25.79 | $19.4K | 11,086 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2024-03-11 | 2024-03-12 | 2,561 | — | $0 | 11,838 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2024-03-11 | 2024-03-12 | 3,295 | — | $0 | 10,245 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2024-03-11 | 2024-03-12 | 968 | $25.42 | $24.6K | 9,277 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2023-10-01 | 2023-10-03 | 2,491 | — | $0 | 0 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2023-10-01 | 2023-10-03 | 732 | $18.63 | $13.6K | 5,052 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2023-10-01 | 2023-10-03 | 2,491 | — | $0 | 5,784 | SEC↗ |